Suvaxyn Circo RSS Authorised This medicine is authorised for use in the European Union porcine circovirus vaccine (inactivated, recombinant) Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Suvaxyn Circo Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Suvaxyn Circo : EPAR - Summary for the public English (EN) (81.94 KB - PDF)First published: 20/04/2018 Last updated: 14/10/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View español (ES) (81.97 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View čeština (CS) (93.99 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View dansk (DA) (83.34 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View français (FR) (82.44 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View íslenska (IS) (83.29 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View italiano (IT) (82.29 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View magyar (HU) (94.15 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Malti (MT) (95.95 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View norsk (NO) (82 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View polski (PL) (95.62 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View português (PT) (83.01 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View română (RO) (94.17 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Suomi (FI) (81.54 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View svenska (SV) (82.05 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Product information Suvaxyn Circo : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 20/04/2018 Last updated: 14/10/2025 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View español (ES) (81.51 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View čeština (CS) (92.48 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View dansk (DA) (82.05 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Deutsch (DE) (81.72 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View eesti keel (ET) (81.22 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View ελληνικά (EL) (91.79 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View français (FR) (81.63 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View hrvatski (HR) (91.56 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View íslenska (IS) (81.52 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Gaeilge (GA) (81.36 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View italiano (IT) (81.76 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View latviešu valoda (LV) (92.14 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View magyar (HU) (92.76 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Malti (MT) (93.86 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Nederlands (NL) (81.15 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View norsk (NO) (81.52 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View polski (PL) (93.22 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View português (PT) (82.53 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View română (RO) (91.73 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View slovenčina (SK) (81.75 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View slovenščina (SL) (81.76 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Suomi (FI) (81.11 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View svenska (SV) (81.47 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Suvaxyn Circo : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 20/04/2018 Last updated: 14/10/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View español (ES) (81.97 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View čeština (CS) (93.99 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View dansk (DA) (83.34 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View français (FR) (82.44 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View íslenska (IS) (83.29 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View italiano (IT) (82.29 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View magyar (HU) (94.15 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Malti (MT) (95.95 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View norsk (NO) (82 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View polski (PL) (95.62 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View português (PT) (83.01 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View română (RO) (94.17 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Suomi (FI) (81.54 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View svenska (SV) (82.05 KB - PDF) First published: 20/04/2018 Last updated: 14/10/2025 View Product details Name of medicine Suvaxyn Circo Active substance porcine circovirus vaccine (inactivated, recombinant) International non-proprietary name (INN) or common name porcine circovirus vaccine (inactivated, recombinant) Pharmacotherapeutic groupImmunologicals for suidaeInactivated viral vaccines Authorisation details EMA product number EMEA/V/C/004242 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Suvaxyn Circo : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 06/11/2018 Last updated: 14/10/2025 View Initial marketing authorisation documents Suvaxyn Circo : EPAR - Public assessment report English (EN) (81.49 KB - PDF)First published: 20/04/2018 Last updated: 14/10/2025 View CVMP summary of positive opinion for Suvaxyn CircoAdopted Reference Number: EMA/CVMP/757567/2017 English (EN) (69.41 KB - PDF)First published: 08/12/2017 Last updated: 08/12/2017 View News on Suvaxyn Circo Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 202310/11/2023 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 202221/01/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 202119/03/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 19-20 January 202122/01/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-9 September 202011/09/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 21-23 January 202024/01/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 8-10 October 201911/10/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 June 201921/06/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 22-24 January 201925/01/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5–7 December 201708/12/2017 Topics Medicines Vaccines This page was last updated on 14/10/2025 Share this page